Net clinical benefit analysis of radiation therapy oncology group 0525: a phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma (Q37278376)
Jump to navigation
Jump to search
scientific article published on 07 October 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Net clinical benefit analysis of radiation therapy oncology group 0525: a phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma |
scientific article published on 07 October 2013 |
Statements
1 reference
Net clinical benefit analysis of radiation therapy oncology group 0525: a phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma (English)
1 reference
Maria Werner-Wasik
1 reference
Andrew Bottomley
1 reference
Terri S Armstrong
1 reference
Jeffrey S Wefel
1 reference
Meihua Wang
1 reference
Mark R Gilbert
1 reference
Minhee Won
1 reference
Tito R Mendoza
1 reference
Corneel Coens
1 reference
David G Brachman
1 reference
Ali K Choucair
1 reference
7 October 2013
1 reference
1 reference
4076-4084
1 reference
Identifiers
1 reference
1 reference
1 reference